King Wealth Halozyme Therapeutics, Inc. Transaction History

King Wealth

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$31.97 - $41.06 $159,850 - $205,300	-5,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$38.84 - $51.31 $194,200 - $256,550	-5,000 Reduced 50.0%	5,000 $227,000
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $197,550 - $257,250	-5,000 Reduced 33.33%	10,000 $417,000
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $51,620 - $87,240	-2,000 Reduced 11.76%	15,000 $641,000
Q2 2020 Aug 13, 2020	SELL	$16.25 - $26.81 $81,250 - $134,050	-5,000 Reduced 22.73%	17,000 $456,000
Q1 2020 May 13, 2020	BUY	$13.9 - $21.83 $305,800 - $480,259	22,000 New	22,000 $396,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.